U.S. prescription drug prices fell 0.8% in July and 3.1% over the prior 12 months according to reported data. Officials attributed part of the savings to existing platforms and international pricing deals while noting continuity with prior Medicare policies. Polling and usage surveys indicate broad public reliance on medications and concern over costs.